Profile
Dr. Wang Jian graduated from the six-year medical program of Jinan University Medical College in 1988 and completed his postgraduate studies at Southern Medical University in 2008. He worked in the Oncology Department of the affiliated Shunde People's Hospital (a Grade III Class A hospital) of Southern Medical University for nearly 30 years. He studied under Professor Luo Pengfei, a leading figure in Chinese interventional medicine, for 29 years, meticulously researching and mastering the Cheng's Microneedle Technique. With over 30 years of experience in interventional medicine, he has personally performed more than 10,000 interventional procedures. He has been awarded Scientific and Technological Progress prizes by the Foshan Municipal Government and the Shunde District Government. He has published over ten academic papers in national medical journals, receiving widespread acclaim.
Positions
· Standing Director, Third Session of China Women and Children Interventional Alliance
· Standing Committee Member, Committee of Tumor Chemotherapy, Guangdong Association of Integrated Traditional and Western Medicine
· Committee Member, Liver Cancer Professional Committee, Guangdong Anti-Cancer Association
· Committee Member, Committee of Tumor Imaging and Interventional Diagnosis & Treatment, Guangdong Anti-Cancer Association
· Committee Member, Interventional Physicians Working Committee, Guangdong Medical Doctor Association
· Expert Panel Member, Guangdong Medical Accident Appraisal Committee
Speciality
Co-inventor of the "Luo Pengfei Cheng's Method for Tumor Diagnosis and Therapy," which is protected by international patent. Based on the thesis that the biological activity of tumors can be inactivated, this clinical approach follows an anti-cancer trilogy—controlling, shrinking, and inactivating tumors—targeting the inactivation of tumor biological activity via the Cheng's minimally invasive method for treating malignant tumors.
Proficient in the comprehensive application of various minimally invasive techniques for treating oncologic and non-oncologic diseases, including:
· Transarterial chemoembolization (TACE) and infusion for solid tumors such as liver cancer, lung cancer, kidney cancer, bladder cancer, and gynecological and head & neck cancers.
· Local ablation therapy for malignant tumors, including microwave ablation, radiofrequency ablation, and argon-helium cryoablation.
· Iodine-125 radioactive seed implantation for malignant tumors.
· Vertebroplasty for vertebral compression fractures.
· Embolization therapy for uterine fibroids and hepatic hemangiomas.
· Metallic stent placement for vascular stenosis, esophageal stenosis, and biliary tract stenosis caused by tumor compression.
· Emergency embolization for hemostasis in cases of massive hemoptysis, traumatic liver/kidney rupture hemorrhage, gastrointestinal bleeding, and postpartum hemorrhage.
· Chemotherapy, targeted therapy, and immunotherapy for solid tumors.
· Transjugular intrahepatic portosystemic shunt (TIPS) for liver cirrhosis and catheter drainage for intestinal obstruction.
